Vulcan Fast Red Chromogen Kit 2, part of an immunohistochemistry (IHC) procedure using an alkalin...
FDA Device Recall #Z-2360-2018 — Class II — April 24, 2018
Recall Summary
| Recall Number | Z-2360-2018 |
| Classification | Class II — Moderate risk |
| Date Initiated | April 24, 2018 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Biocare Medical, LLC |
| Location | Pacheco, CA |
| Product Type | Devices |
| Quantity | 43 units |
Product Description
Vulcan Fast Red Chromogen Kit 2, part of an immunohistochemistry (IHC) procedure using an alkaline phosphatase (AP) detection system. Catalog numbers FR805-5L and FR805S
Reason for Recall
Chromogen failed to develop due to a stability issue caused by environmental factors with a raw material in the Vulcan Fast Red Buffer.
Distribution Pattern
CA, VT, KY, LA, OR, RI, GA, IL, MA, TX, KS, FL, Japan, and Germany
Lot / Code Information
Lot numbers 011818 and 022818
Other Recalls from Biocare Medical, LLC
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0315-2025 | Class II | intelliPATH Universal HRP Detection Kit, REF: I... | Sep 25, 2024 |
| Z-1333-2021 | Class II | BIOCARE Medical , IntelliPath FLX, Automated St... | Feb 25, 2021 |
| Z-2291-2020 | Class II | 4plus Streptavidin HRP Label, Conjugated Strep... | Oct 10, 2019 |
| Z-3198-2018 | Class II | URO-3 Triple Stain (CD44 + p53) with CK20, Cata... | Mar 15, 2018 |
| Z-1523-2016 | Class III | Mach 4 Mouse Probe vial within the Mach 4 Unive... | Mar 31, 2016 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.